Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Non-cash Items (2020 - 2023)

Barinthus Biotherapeutics filings provide 4 years of Non-cash Items readings, the most recent being $4.1 million for Q3 2023.

  • On a quarterly basis, Non-cash Items fell 52.87% to $4.1 million in Q3 2023 year-over-year; TTM through Sep 2023 was $4.1 million, a 52.87% decrease, with the full-year FY2022 number at $7.1 million, down 43.2% from a year prior.
  • Non-cash Items hit $4.1 million in Q3 2023 for Barinthus Biotherapeutics, down from $6.5 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $19.8 million in Q2 2021 to a low of $3.1 million in Q4 2020.
  • Median Non-cash Items over the past 4 years was $8.8 million (2022), compared with a mean of $9.9 million.
  • Biggest five-year swings in Non-cash Items: surged 304.66% in 2021 and later tumbled 52.87% in 2023.
  • Barinthus Biotherapeutics' Non-cash Items stood at $3.1 million in 2020, then skyrocketed by 304.66% to $12.5 million in 2021, then crashed by 43.2% to $7.1 million in 2022, then tumbled by 42.25% to $4.1 million in 2023.
  • The last three reported values for Non-cash Items were $4.1 million (Q3 2023), $6.5 million (Q2 2023), and $9.0 million (Q1 2023) per Business Quant data.